Interchange Capital Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $202K | Buy |
|
|||||
|
2025
Q2 | $100K | Sell |
|
|||||
|
2025
Q1 | $84.4K | Sell |
|
|||||
|
2024
Q4 | $163K | Sell |
|
|||||
|
2024
Q3 | $417K | Buy |
|
|||||
|
2024
Q2 | $456K | Buy |
|
|||||
|
2024
Q1 | $303K | Buy |
|
|||||
|
2023
Q4 | $311K | Buy |
|
|||||
|
2023
Q3 | $305K | Buy |
|
|||||
|
2023
Q2 | $363K | Sell |
|
|||||
|
2023
Q1 | $448K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $441K | Sell |
|
|||||
|
2022
Q2 | $451K | Sell |
|
|||||
|
2022
Q1 | $639K | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $1.1M | Buy |
|
|||||
|
2021
Q2 | $1.25M | Sell |
|
|||||
|
2021
Q1 | $2.19M | Sell |
|
|||||
|
2020
Q4 | $1.6M | Buy |
|